Thermo Fisher Scientific

Cell and gene therapies are entering a transformative era, offering new hope and potential cures to patients. Our Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, California is the latest addition to a global network dedicated to accelerating the development of these personalized treatments. Equipped with state-of-the-art technologies, the 6,000-square-foot ATxCC is staffed with experts who will support our biotech and biopharma partners in taking their innovative therapies from the clinical trial stage into commercial scale. "By fostering collaboration and innovation, the center is poised to play a pivotal role in helping to advance cell therapies, ultimately improving patient lives,” says Thermo Fisher’s Betty Woo. Learn more about how the ATxCC will enable our customers to make potentially life-changing cell and gene therapies more accessible to patients: https://lnkd.in/gDqYVNfw

Every student has the potential to become an innovator in STEM. Through our national partnership with the Boys & Girls Clubs of America, we expose students to STEM fields through hands-on learning experiences and our dedicated colleague volunteers--including scientists, engineers, technologists and innovators who are working to solve some of the world's most complex challenges. Read more about the importance of fostering the next-generation of life sciences leaders in Axios Boston: https://lnkd.in/eSF2qDQJ

When Amelia Garcia was born with severe heart complications, a transplant offered her family hope for a future, thanks, in large part, to research and innovation driven by collaborations among academia, industry and essential funding from The National Institutes of Health (NIH). The NIH funds research that leads to transplant diagnostic technologies like those from Thermo Fisher that have revolutionized donor-recipient matching—now an essential part of transplantation, says Tina Liedtky. These innovations directly benefit patients like Amelia and their families, reducing invasive procedures and improving post-transplant quality of life. Today, Amelia's mother says, she is growing and thriving, thanks to the transformative power of transplantation. Learn more about how collaboration between the NIH, academia and industry gives transplant patients hope—and a chance at life: https://lnkd.in/gQeBgVk4

This week we were honored to welcome a bipartisan group of Members of Congress to two of our U.S. sites. In Richmond, VA, Congresswoman Jennifer McClellan and Congressman Rob Wittman visited our site, home to one of the world’s largest bioanalytical laboratories. During their tour, we highlighted our specialized immunochemistry work and the critical role life sciences play in driving innovation. We’re grateful for their shared commitment to supporting research, discovery, and the patients our customers serve. Meanwhile, in Rockford, IL, we hosted Congressman Darin LaHood, who toured the R&D, manufacturing and distribution areas where we make and ship products that help customers study protein functions in key fields like biochemistry, neurobiology, toxicology, and cancer research. Congressman LaHood also spoke directly with colleagues about the impact of their innovative work. Thank you, Congresswoman McClellan, Congressman Wittman, and Congressman LaHood, for fostering meaningful dialogues and championing critical life sciences innovation. Together, we will continue to push the boundaries of research and healthcare.

Thermo Fisher's additional $2 billion investment in the United States over the next four years includes $1.5 billion in capital expenditures to enhance and expand U.S. manufacturing operations and $500M in R&D focused on high impact innovation. This investment builds on Thermo Fisher’s industry-leading foundation in U.S. manufacturing and innovation and underscores our commitment to supporting a resilient U.S. healthcare supply chain. Learn more: https://lnkd.in/epWGqnuq

Today, we announced our first quarter 2025 financial results. Learn more: https://lnkd.in/gkTJK365

🌍 We recognize our responsibility to protect and preserve our planet. We drive positive change by designing more sustainable products and packaging, powering our sites with renewable energy, innovating solutions for greener technologies, safer air and water quality, and more. On Earth Day, and every day, we're dedicated to a greener tomorrow.

Warmer weather and blooming flowers bring joy and... allergies. Understanding your allergy triggers is key to managing symptoms like sneezing, itchy eyes, and stuffy noses. Advanced diagnostics can measure sensitizations to a wide range of allergens—pollens, weeds, molds and more—providing clinicians with the insights they need for accurate diagnoses and comprehensive treatment plans. Learn more about how clinicians use Thermo Fisher's ImmunoCAP allergy diagnostics to care for their patients: https://lnkd.in/eRBCpDWB

Labs can consume up to 10x the energy and 4x the water of standard office spaces, significantly impacting the environment. To combat this, life science organizations are leveraging their technical expertise and innovative solutions to introduce greener practices. Nonprofit My Green Lab is leading the charge through educational programs and initiatives with companies like Thermo Fisher to help ensure labs and suppliers are advancing sustainability, from product design to site operations and more. In the spirit of Earth Day this month, James Connelly, CEO of My Green Lab, and Alyssa Caddle, Director of Global Sustainability at Thermo Fisher, joined the Science with a Twist podcast to discuss the importance and business value of sustainability initiatives in lab environments. Learn more about the value of collaboration in driving sustainable practices in our latest episode, found on our website or wherever you listen to podcasts: https://lnkd.in/gVRDHTSi

Recently, I had the opportunity to visit three Thermo Fisher sites in the U.S. – including our pharma services facility in St. Louis, Missouri, and our clinical research services facilities in Highland Heights, Kentucky, and Morrisville, North Carolina. These operations support our biotech and pharmaceutical customers in bringing new medicines to patients by providing services that support the entire drug-development journey. · Our Highland Heights site is home to our central laboratory services, which provides analytical testing for all stages of clinical trials. · Our St. Louis site is focused on developing and manufacturing biologic drugs for diseases such as psoriasis, hemophilia and various types of cancer. · Our teams in Morrisville provide clinical development and patient and advisory services -- designing and managing clinical trials, from early development through post-approval. At all three sites, it was inspiring to see the outstanding work our colleagues are doing to fulfill our Mission to enable our customers to make the world healthier, cleaner and safer. And, it was great to engage with these teams in person. To our colleagues all over the world, thank you for the work you do every day, which makes a huge difference for our customers and our world.